Mercedes Robledo
Instituto de Salud Carlos III(ES)Spanish National Cancer Research Centre(ES)Centre for Biomedical Network Research on Rare Diseases(ES)Centro de Investigación Biomédica en Red(ES)Cancer Research Center(US)Universidad ISA(DO)Universidad Tecnológica de Santiago(DO)Centro de Investigación del Cáncer(ES)Cancer Genetics (United States)(US)Research Network (United States)(US)Centro de Investigación Biomédica en Red de Cáncer(ES)Instituto de Investigación de Enfermedades Raras(ES)
Publications by Year
Research Areas
Adrenal and Paraganglionic Tumors, Cancer, Hypoxia, and Metabolism, Pituitary Gland Disorders and Treatments, Hormonal Regulation and Hypertension, Thyroid Cancer Diagnosis and Treatment
Most-Cited Works
- → Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma(2011)528 cited
- → Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas(2013)390 cited
- → Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension(2020)383 cited
- → MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma(2012)326 cited
- → An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes(2012)284 cited
- → SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma(2010)269 cited